Aurora (ACB): Rega marang dodolan

Tandha merek Aurora (ACB)

Aurora Cannabis focuses on the export of high-cost medical products and scientific research. Fluctuations in the P/S multiple reflect the dynamics of market valuation relative to revenue, with the latest reading standing at 1.60. Reducing reliance on the Canadian recreational segment in favor of overseas pharmacies strengthens the business. Success is now based on cutting operating expenses and expanding into Australia and Europe.

ACB: Multiplikator P/S auroramj.com 04.07.2022 - 14.11.2026

Rincian analitis perusahaan Aurora Cannabis (ACB)

- rega saham lan konsensus proyeksi valuasi:
Bagan owah-owahan rega auroramj.com|ACB - Bagan rega target
- data kapitalisasi bursa:
Nilai pasar Aurora|ACB - Nilai Total Perusahaan
- data nilai buku modal saham:
Nilai Akuntansi Saham Aurora Cannabis|ACB - Kapitalisasi Buku|Rasio Kapitalisasi Pasar marang Nilai Buku auroramj.com|ACB - Gunggung Aset Perusahaan
- indikator beban kredit lan likuiditas emiten:
Rasio Kabeh Utang marang Dana Pribadi Aurora Cannabis|ACB - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas auroramj.com|ACB - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Aurora|ACB - Utang jangka dawa perusahaan|Tanggungan utang jangka cendhak perusahaan Aurora Cannabis|Rasio likuiditas darurat auroramj.com
- informasi bathi lan kelipatan valuasi:
ACB - Bathi resik|Proyeksi bathi mangsa ngarep Aurora Cannabis|ACB - Pangali P/E|Rega marang bathi mangsa ngarep auroramj.com|ACB - Pangali PEG|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan Aurora|ACB - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben saham sajrone patang kuartal pungkasan Aurora Cannabis|ACB - Bathi resik saben saham (EPS TTM)|Wutah bathi EPS kuartalan auroramj.com|ACB - Wutah bathi ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Aurora Cannabis
- rincian pendapatan lan dodolan emiten:
ACB - Pendapatan lan volume dodolan|Prakiraan pendapatan perusahaan auroramj.com|ACB - Rasio rega marang pendapatan|Kapitalisasi marang prakiraan pendapatan Aurora
Analisis umum perusahaan:ACB Aurora Cannabis, Inc.
Produk dadi Aurora Cannabis Inc.

Geopolitical export restrictions and rising energy costs for greenhouses directly impact the revenue of Aurora Cannabis (ACB), determining the market value of its assets. The current 1.60 metric reflects the ratio of market capitalization to sales volume, allowing investors to assess the premium paid per unit of income and analyze P/S multiple fluctuations to identify a fair entry point into the asset.

Pesaing Aurora Cannabis

INDV (indivior.com) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Collegium Pharmaceutical, Inc. COLL|Cronos Group Inc (CRON) - Rega marang dodolan|CGC - Rasio rega marang pendapatan|Rasio kapitalisasi pasar marang pendapatan HITI (Canna Cabana)|ACHV: Multiplikator P/S|skyebioscience.com (SKYE) - Multiplikator P/S|Kapitalisasi marang pendapatan ANEB|INCR: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S NTRB|Kapitalisasi marang pendapatan nasuspharma.com NSRX|Multiplikator P/S IGC (IGC Pharma)|Multiplikator P/S MIRA Pharmaceuticals Inc. MIRA|FLGC - Rasio rega marang pendapatan|IMCC (IM Cannabis Corp.) - Rasio kapitalisasi marang pendapatan|adialpharma.com (ADIL) - Rasio rega marang pendapatan|Rasio kapitalisasi marang pendapatan ARTL|ENSC (Ensysce Biosciences Inc.) - Multiplikator P/S|Multiplikator P/S Titan Pharma|Multiplikator P/S GNLN|Rasio rega marang pendapatan INM (InMed Pharmaceuticals Inc)|Multiplikator P/S AKAN (Akanda Corporation)|Koefisien rega marang pendapatan Enveric Corp (ENVB)|BGXX - Rasio rega marang pendapatan|Koefisien rega marang pendapatan Hempacco Co Inc. HPCO